Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Efti Plus Pembrolizumab Is Effective in 2nd-Line PD-1/PD-L1-Resistant Metastatic NSCLC Pts Aug 11, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),SCLC (Small Cell Lung Cancer) Patterns of response in mNSCLC after 2 and 4 CT cycles Aug 11, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),Other Cancers CEMI Monotherapy as 1L Treatment of Pts With Brain Metastases From aNSCLC Aug 07, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) 1L Cemiplimab for laNSCLC: Updated Subgroup Analyses Aug 03, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Updated Efficacy and Safety of Taletrectinib in Pts With ROS1+ NSCLC Jul 31, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Updated Data on DFS, OS, and Safety in Pts Receiving Adj Atezo After Neoadj Atezo Jul 31, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Tumor Growth Inhibition-OS Model: Alectinib Data Validation Jul 27, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Atezolizumab Monotherapy vs Single-Agent Chemotherapy in Platinum-Ineligible NSCLC Patients Jul 19, 2023
